You win some, you lose some, and you go to court again. That was the story for Eli Lilly and Co. in the
past week. The Indianapolis-based drugmaker suffered the biggest theft of pharmaceuticals in history when $75 million worth
of drugs were stolen from a Connecticut warehouse. The company expects its insurance to cover the losses. Meanwhile, Lilly
won a court appeal against Massachusetts-based Ariad Pharmaceuticals Inc., according to Bloomberg News. That decision nullified
a $65.2 million verdict won by Ariad for royalties on Lilly’s osteoporosis drug Evista and sepsis medicine Xigris. But
Lilly plunged into a new patent dispute, this time suing the U.S. unit of Dutch drugmaker Synthon BV to prevent it from selling
a generic version Adcirca. The drug, which was approved last year, uses the same active ingredient as Lilly’s anti-impotence
pill Cialis to treat lung problems.
The Fairbanks Institute for Healthy Communities has created a repository in Indianapolis for scientists
to research diseases associated with aging and ideally help develop more effective medicines. The INbank stores biological
samples along with the history and clinical outcome of the corresponding patient.
The Alfred Mann Institute for Biomedical Development in West Lafayette is funding work by two Purdue University
professors that could allow for almost immediate readings on the concentration of a drug in a patient’s blood. The technology,
being developed by Zheng Ouyang, a professor of biomedical engineering, and R. Graham Cooks, an analytical chemistry professor,
could be used in hospitals, doctor's offices or as part of clinical trials. Also, by not sending the blood sample to an
off-site lab, the test could cost far less.
Indianapolis-based Diversity Accords LLC and the Indiana Health Industry Forum have formed
a partnership to help minority-owned suppliers identify and respond to opportunities within the health and life sciences industries.
Members of the Health Industry Forum can receive a discount off Diversity Accords’ monthly association fee. Diversity
Accords has been tapped by such companies as Illinois-based Hospira Inc. and California-based Kaiser-Permanente to meet their
objectives on using minority-owned companies as suppliers.